Compare use cases
Drop two or three slugs into the URL — for example ?slugs=demo-mia-breast-screening,demo-idx-dr-retinopathy — or pick from the validated catalogue below.
Pick from validated:
AI imaging triage for the acute stroke pathwayAI second reader for breast cancer screeningAutonomous diabetic retinopathy screening in primary carePre-operative risk-stratification model for major surgerySelf-referral assistant for NHS Talking TherapiesType-2 diabetes long-term outcome predictor
Clear selection| Type-2 diabetes long-term outcome predictor Netherlands | Self-referral assistant for NHS Talking Therapies United Kingdom | |
|---|---|---|
| Trust badge | Validated | Validated |
| Evidence strength | Robust evidence | Developing evidence |
| Pipeline stage | Validated | Validated |
| Intended use | Estimates 5-year risk of major diabetes-related complications (cardiovascular, renal, retinal) from longitudinal primary-care records to support care-plan intensification. | Supports patient self-referral by collecting clinical information conversationally and routing referrals, reducing administrative wait time. |
| Specialty | Endocrinology | Psychiatry |
| Autonomy | Informs a human (advisory) | Human in the loop (human acts) |
| Deployment | Active deployment | Active deployment |
| EU AI Act tier | High-risk | Limited risk |
| EU MDR class | Not a device | Not a device |
| CE marking | Not required | Not required |
| NICE ESF tier | Tier C — treat / diagnose / calculate risk | Tier B — inform / monitor |
| Headline metric | AUC / AUROC: 0.82 | Accuracy: 0.93 |
| Subgroup assessed | Yes | Yes |